Vector-borne diseases (VBDs) pose a significant threat to public health in India, driven by a combination of environmental, socio-economic, and healthcare factors. This article provides an in-depth analysis of the situation and suggests strategies for combatting this rising tide.
VBDs, such as dengue, malaria, and chikungunya, account for more than 17% of all infectious diseases in India. They contribute to economic instability and increased healthcare costs. The country's vast population, coupled with inadequate health infrastructure and environmental factors, make VBDs a persistent challenge.
Efforts to control VBDs are hampered by a variety of factors. These include rapid urbanization, climate change, and the lack of access to clean water and sanitation. The widespread use of insecticides has also led to the emergence of resistant vector species, further complicating control measures.
Effective control of VBDs requires a multi-faceted approach. This includes strengthening health infrastructure, improving surveillance systems, and promoting community involvement. Integrated vector management (IVM) strategies, which combine chemical and biological control methods with habitat modification, can also be highly effective.
Healthcare professionals have a crucial role in controlling VBDs. They are pivotal in early detection, prompt treatment, and patient education. Their involvement in policy-making can also contribute to the development of more effective, sustainable strategies for VBD control.
Combatting the rising tide of VBDs in India requires a comprehensive, coordinated approach. By strengthening healthcare systems, implementing effective vector control strategies, and leveraging the expertise of healthcare professionals, it is possible to mitigate the impact of these diseases and protect public health.
1.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
2.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
3.
Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Long-Acting Interferon Therapy Approved for ET
1.
Molecular Network Mapping in Hematologic Disease
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
4.
Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange
5.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Common side effects of cancer treatment and how they are managed
3.
Clinical Excellence in Hematology
4.
Best Practices in Hematology
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation